Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First-line tagraxofusp leads to durable responses and prolonged survival in adults with blastic plasmacytoid dendritic cell neoplasm regardless of fitness level.

Haematologica·2026
Same author

Hematopoietic effects of tagraxofusp in treatment-naive patients with blastic plasmacytoid dendritic cell neoplasm.

Cancer·2026
Same author

Durable post-transplant survival after first-line tagraxofusp for blastic plasmacytoid dendritic cell neoplasm.

Leukemia & lymphoma·2025
Same author

Exploring Perspectives on Feasibility, Challenges, and Support Needs for Chlorhexidine Gluconate (CHG) Bathing in the Outpatient Setting for Hematopoietic Cell Transplant Recipients: A Qualitative Study.

Transplantation and cellular therapy·2025
Same author

Prolonged chimeric antigen receptor-T apheresis to infusion time is associated with inferior outcomes in diffuse large B-cell lymphoma.

British journal of haematology·2025
Same author

Machine Learning Algorithm to Explore Patients With Heterogeneous Treatment Effects of Clinically Significant CMV Infection and Non-Relapse Mortality After HSCT.

EJHaem·2025

Related Experiment Video

Updated: Jun 11, 2026

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice
03:40

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice

Published on: December 8, 2023

Haploidentical transplantation for leukemia.

Junya Kanda1, Nelson J Chao, David A Rizzieri

  • 1Division of Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, NC 27705, USA.

Current Oncology Reports
|July 6, 2010
PubMed
Summary
This summary is machine-generated.

Hematopoietic stem cell transplants from half-matched family donors are a viable option when matched donors are unavailable. Research focuses on improving immune recovery post-transplant to reduce infections and relapse rates.

More Related Videos

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
11:55

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

Intra-Peritoneal Transplantation for Generating Acute Myeloid Leukemia in Mice
10:02

Intra-Peritoneal Transplantation for Generating Acute Myeloid Leukemia in Mice

Published on: January 6, 2023

Related Experiment Videos

Last Updated: Jun 11, 2026

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice
03:40

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice

Published on: December 8, 2023

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
11:55

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

Intra-Peritoneal Transplantation for Generating Acute Myeloid Leukemia in Mice
10:02

Intra-Peritoneal Transplantation for Generating Acute Myeloid Leukemia in Mice

Published on: January 6, 2023

Area of Science:

  • Immunotherapy
  • Hematology
  • Transplantation Immunology

Background:

  • Allogeneic immunotherapy using hematopoietic stem cell transplantation (HSCT) is crucial for treating various hematologic disorders.
  • Human leukocyte antigen (HLA)-haploidentical family donors offer a readily available alternative when HLA-matched donors are scarce.
  • Traditional HLA-haploidentical HSCT faced challenges including graft-versus-host disease and delayed immune reconstitution.

Purpose of the Study:

  • To review advancements in HLA-haploidentical HSCT techniques.
  • To highlight strategies for mitigating risks and improving outcomes in these transplants.
  • To discuss novel approaches for enhancing immune recovery post-transplant.

Main Methods:

  • Ex vivo T-cell depletion with immuno-myeloablative conditioning.
  • In vivo T-cell depletion with reduced-intensity conditioning.
  • Investigating donor lymphocyte infusions (DLIs) and modified T-cell strategies.
  • Exploring the role of donor natural killer (NK) cells in post-transplant immunity.

Main Results:

  • Durable donor engraftment achieved with reduced acute graft-versus-host disease (GVHD) using T-cell depleted grafts.
  • Minimized transplant-related risks through modified conditioning and T-cell depletion strategies.
  • Persistent challenges include delayed immune reconstitution, leading to infections and potential disease relapse.

Conclusions:

  • HLA-haploidentical HSCT is a feasible and increasingly safe allogeneic immunotherapy option.
  • Future research focusing on enhancing immune reconstitution, particularly with NK cells and modified T-cells, is critical.
  • Optimizing post-transplant immune recovery will improve the efficacy and broaden the applicability of haploidentical HSCT.